OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before diagnosis. Powered by AI and validated across global datasets, the breakthrough ...

Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...

Spread the love“`html Advancements in technology have ushered in a new era of healthcare, particularly in the field of cancer detection. Recently, researchers at Stanford University unveiled a ...

Noninvasive imaging biomarkers for survival risk stratification with tarlatamab in ES-SCLC. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full ...

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...

Explore whether Canakinumab can prevent lung cancer, focusing on new research and the complexities of medical interpretations ...

Lung cancer is one of the major causes of cancer-related fatalities in the global society, particularly due to its late diagnosis in most cases. Early diagnosis has great benefits in terms of survival ...